StatSure Diagnostic Systems (SSUR)

[Ubertino]

I have now, thanks to you. And I read this PR, too:

May 31, 2007 - 6:30 AM EDT

StatSure Diagnostic Systems CEO Featured in Exclusive Interview With WallSt.net

NEW YORK, May 31 /PRNewswire-FirstCall/ -- On May 23, Steve Peltzman, CEO for StatSure Diagnostic Systems, Inc. (OTC Bulletin Board: SSUR) updated the investment community in an exclusive interview with www.wallst.net. Topics covered in the interview include an overview of the Company and the markets it serves, recent press releases, current capitalization, upcoming strategic and financial milestones.

To hear the interview in its entirety, visit www.wallst.net, and click on 'Interviews.' The interview can be accessed either by locating the company's ticker symbol under the appropriate exchange on the left-hand column of the 'Interviews' section of the site, or by entering the company's ticker symbol in the Search Archive window.

About StatSure Diagnostic Systems:

StatSure Diagnostic Systems, Inc. is engaged in the development, manufacture and marketing of rapid immunoassay tests for the detection of sexually transmitted and other infectious diseases; in addition, the Company has developed and is marketing a product line of patented, oral-fluid collection devices. The Company's proprietary platforms provide significant customer benefits and competitive advantages as compared to similar products that are currently available. Improved accuracy, operator convenience, and reduced risk of infection from collecting and handling specimens, have been engineered into SDS products. All of the company's diagnostic tests are based on the same easy-to-use technology platform, thus facilitating the development of future products. Certain of these products are sold in the United States as well as internationally to various distributors for use in clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations.

For more information about the company, please visit http://www.statsure.com .

About WallSt.net:

www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. The website is a leading provider of financial news, media, tools and community-driven applications for investors. www.wallst.net offers visitors free membership to its in-depth executive interviews, exclusive editorial content, breaking news, and several proprietary applications. In addition to its website, WallStreet Direct organizes investor conferences, publishes a newspaper, and provides multimedia advertising solutions to small and mid-sized publicly traded companies. We are expecting to receive two hundred eighty dollars from StatSure Diagnostic Systems, Inc. for the dissemination of this press release. For a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO )

SOURCE WallStreet Direct, Inc.

Source: PR Newswire (May 31, 2007 - 6:30 AM EDT)

http://app.quotemedia.com/quotetools/popups/story.jsp

Looks good - I particularly liked the 'avian flu' and 'P&G' mentions. With P&G involved with an avian flu home use test device - I see mega sales. I think we are looking at an NNVC clone - albeit in a somewhat different but related field.